Going forward, we may see more instances in which insurers deny or (temporarily) severely restrict coverage of accelerated ...
However, the agency’s inexplicable delay in doing so raises serious questions about the FDA’s bureaucratic and unaccountable ...
The Health and Human Services Office of Inspector General has found that, in a few cases, FDA officials veered from the accelerated approval pathway.
Amid the uproar over the firing of 18 inspectors general, a report offering a coda to the aducanumab approval episode has ...
Terra Wonsettler, PharmD, MBA, vice president of pharmacy for Evolent, discusses the recent HHS OIG report that stemmed from ...
Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...
10d
Verywell Health on MSNSpravato Nasal Spray Can Now Be Used Alone for Treatment-Resistant DepressionPeople with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals ... s modest effectiveness and lengthy development process underscore the challenges of finding new ways to manage ...
That gave the FDA a way to communicate expectations to drugmakers about how clinical trials should be conducted to support a drug approval ... There is a formal process for removing guidance ...
At the end of 2024, more than 50 authorized treatment centers in the U.S. had initiated the treatment process with over 50 patients. In December, the FDA approved Alyftrek, a new once-daily pill ...
A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results